Skip to main content
Erschienen in: Updates in Surgery 2/2016

13.06.2016 | Position Paper

Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it

verfasst von: Guido Torzilli, Luca Viganò, Felice Giuliante, Antonio Daniele Pinna

Erschienen in: Updates in Surgery | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

During the last decades, liver surgery had an extraordinary evolution and diffusion thanks to a drastic reduction of operative mortality and morbidity rates. A debate is ongoing about the need for centralization of liver resections in tertiary referral centers. Robust evidences showed that complex surgical procedures have lower mortality rates when performed in high-volume centers. The present expert group reviewed the literature data and proposed guidelines to identify surgical units that should be entitled to perform liver surgery in Italy. Three separate types of requirements were identified. First, the hospital requirements that include the following criteria: (1) a hospital of 1st level according to the Italian law; (2) the presence of a dedicated hepatobiliary or hepatobiliopancreatic unit or a team dedicated to liver surgery into a general surgery unit; (3) the mandatory presence of oncology, hepatology, radiology, interventional radiology, digestive endoscopy, intensive care, and pathology units; (4) the availability of a liver transplant team into the hospital or into another hospital within an established partnership; (5) a periodic multidisciplinary meeting. Second, the volume requirements: the unit has to perform more than 20 liver resections per year for malignant liver diseases with a 90-day mortality rate < 3 %. Finally, the organization requirements: the presence of specific diagnostic–therapeutic flowcharts for liver diseases.
Literatur
1.
Zurück zum Zitat Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206CrossRefPubMed Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206CrossRefPubMed
2.
Zurück zum Zitat Poon RT, Fan ST, Lo CM et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–708PubMedPubMedCentral Poon RT, Fan ST, Lo CM et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–708PubMedPubMedCentral
3.
Zurück zum Zitat Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West study group. Ann Surg 257:929–937CrossRefPubMed Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West study group. Ann Surg 257:929–937CrossRefPubMed
4.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397–406CrossRefPubMedPubMedCentral Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397–406CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Giuliante F, Ardito F, Pinna AD et al (2012) Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg 215:244–254CrossRefPubMed Giuliante F, Ardito F, Pinna AD et al (2012) Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg 215:244–254CrossRefPubMed
6.
7.
Zurück zum Zitat Torzilli G, Procopio F, Botea F et al (2009) One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery 146:60–71CrossRefPubMed Torzilli G, Procopio F, Botea F et al (2009) One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery 146:60–71CrossRefPubMed
8.
Zurück zum Zitat Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414CrossRefPubMed Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414CrossRefPubMed
9.
Zurück zum Zitat Giuliante F, Ardito F, Ferrero A et al (2014) Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients. J Am Coll Surg 219:285–294CrossRefPubMed Giuliante F, Ardito F, Ferrero A et al (2014) Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients. J Am Coll Surg 219:285–294CrossRefPubMed
11.
12.
Zurück zum Zitat Viganò L, Conci S, Cescon M et al (2015) Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: a multicenter matched analysis with HCV-related HCC. J Hepatol 63:93–101CrossRefPubMed Viganò L, Conci S, Cescon M et al (2015) Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: a multicenter matched analysis with HCV-related HCC. J Hepatol 63:93–101CrossRefPubMed
13.
Zurück zum Zitat Rubbia-Brandt L, Audard V, Sartoretti P et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460–466CrossRefPubMed Rubbia-Brandt L, Audard V, Sartoretti P et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460–466CrossRefPubMed
14.
Zurück zum Zitat Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072CrossRefPubMed Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072CrossRefPubMed
15.
Zurück zum Zitat Viganò L, Rubbia-Brandt L, De Rosa G et al (2015) Nodular regenerative hyperplasia in patients undergoing liver resection for colorectal metastases after chemotherapy: risk factors, preoperative assessment and clinical impact. Ann Surg Oncol 22:4149–4157CrossRefPubMed Viganò L, Rubbia-Brandt L, De Rosa G et al (2015) Nodular regenerative hyperplasia in patients undergoing liver resection for colorectal metastases after chemotherapy: risk factors, preoperative assessment and clinical impact. Ann Surg Oncol 22:4149–4157CrossRefPubMed
17.
Zurück zum Zitat Ciria R, Cherqui D, Geller DA et al (2016) Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg 263:761–777CrossRefPubMed Ciria R, Cherqui D, Geller DA et al (2016) Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg 263:761–777CrossRefPubMed
18.
Zurück zum Zitat Aldrighetti L, Belli G, Boni L et al (2015) Italian experience in minimally invasive liver surgery: a national survey. Updates Surg 67:129–140CrossRefPubMed Aldrighetti L, Belli G, Boni L et al (2015) Italian experience in minimally invasive liver surgery: a national survey. Updates Surg 67:129–140CrossRefPubMed
19.
Zurück zum Zitat Viganò L, Tayar C, Laurent A, Cherqui D (2009) Laparoscopic liver resection: a systematic review. J Hepatobiliary Pancreat Surg 16:410–421CrossRefPubMed Viganò L, Tayar C, Laurent A, Cherqui D (2009) Laparoscopic liver resection: a systematic review. J Hepatobiliary Pancreat Surg 16:410–421CrossRefPubMed
20.
Zurück zum Zitat Wakabayashi G, Cherqui D, Geller DA et al (2015) Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg 261:619–629PubMed Wakabayashi G, Cherqui D, Geller DA et al (2015) Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg 261:619–629PubMed
21.
Zurück zum Zitat Luft HS, Bunker JP, Enthoven AC (1979) Should Operations Be Regionalized? The Empirical Relation between Surgical Volume and Mortality. N Engl J Med 301:1364–1369CrossRefPubMed Luft HS, Bunker JP, Enthoven AC (1979) Should Operations Be Regionalized? The Empirical Relation between Surgical Volume and Mortality. N Engl J Med 301:1364–1369CrossRefPubMed
22.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137CrossRefPubMed Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137CrossRefPubMed
23.
Zurück zum Zitat Folprecht G et al (2010) Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomises phase 2 trial. Lancet Oncol 11:38–47CrossRefPubMed Folprecht G et al (2010) Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomises phase 2 trial. Lancet Oncol 11:38–47CrossRefPubMed
24.
Zurück zum Zitat Torzilli G (2014) Ultrasound guided liver surgery, Springer, Berlin Torzilli G (2014) Ultrasound guided liver surgery, Springer, Berlin
25.
Zurück zum Zitat Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr (2003) Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138:185–191CrossRefPubMed Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr (2003) Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138:185–191CrossRefPubMed
26.
Zurück zum Zitat Garcea G, Breukink SO, Marlow NE et al (2009) A systematic review of the impact of volume of hepatic surgery on patient outcome. Surgery 145:467–475CrossRefPubMed Garcea G, Breukink SO, Marlow NE et al (2009) A systematic review of the impact of volume of hepatic surgery on patient outcome. Surgery 145:467–475CrossRefPubMed
27.
Zurück zum Zitat Tol JA, van Gulik TM, Busch OR, Gouma DJ (2012) Centralization of highly complex low-volume procedures in upper gastrointestinal surgery. A summary of systematic reviews and meta-analyses. Dig Surg 29:374–383CrossRefPubMed Tol JA, van Gulik TM, Busch OR, Gouma DJ (2012) Centralization of highly complex low-volume procedures in upper gastrointestinal surgery. A summary of systematic reviews and meta-analyses. Dig Surg 29:374–383CrossRefPubMed
28.
Zurück zum Zitat Gruen R, Pitt V, Green S, Parkhill A, Campbell D, Jolley D (2009) The effect of provider case volume on cancer mortality. CA Cancer J Clin 59:192–211CrossRefPubMed Gruen R, Pitt V, Green S, Parkhill A, Campbell D, Jolley D (2009) The effect of provider case volume on cancer mortality. CA Cancer J Clin 59:192–211CrossRefPubMed
29.
Zurück zum Zitat Hyder O, Sachs T, Ejaz A, Spolverato G, Pawlik TM (2013) Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA. J Gastrointest Surg 17:2114–2122CrossRefPubMedPubMedCentral Hyder O, Sachs T, Ejaz A, Spolverato G, Pawlik TM (2013) Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA. J Gastrointest Surg 17:2114–2122CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat McKay A, You I, Bigam D, Lafreniere R, Sutherland F, Ghali W, Dixon E (2008) Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol 15:1348–1355CrossRefPubMed McKay A, You I, Bigam D, Lafreniere R, Sutherland F, Ghali W, Dixon E (2008) Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol 15:1348–1355CrossRefPubMed
31.
Zurück zum Zitat Viganò L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L (2013) Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol 20:938–945CrossRefPubMed Viganò L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L (2013) Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol 20:938–945CrossRefPubMed
32.
Zurück zum Zitat Ravaioli M, Pinna AD, Francioni G et al (2014) A partnership model between high- and low-volume hospitals to improve results in hepatobiliary pancreatic surgery. Ann Surg 260:871–875CrossRefPubMed Ravaioli M, Pinna AD, Francioni G et al (2014) A partnership model between high- and low-volume hospitals to improve results in hepatobiliary pancreatic surgery. Ann Surg 260:871–875CrossRefPubMed
33.
Zurück zum Zitat Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, Ohtomo K, Makuuchi M (1999) Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30:889–893CrossRefPubMed Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, Ohtomo K, Makuuchi M (1999) Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30:889–893CrossRefPubMed
Metadaten
Titel
Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it
verfasst von
Guido Torzilli
Luca Viganò
Felice Giuliante
Antonio Daniele Pinna
Publikationsdatum
13.06.2016
Verlag
Springer Milan
Erschienen in
Updates in Surgery / Ausgabe 2/2016
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-016-0373-0

Weitere Artikel der Ausgabe 2/2016

Updates in Surgery 2/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.